Tag: tobacco heating products

PMI Launches ‘Cleaner’ Bladeless IQOS in Japan

Photo: Kuznietsov Dmitriy
Philip Morris International has launched IQOS Iluma, the brand’s first tobacco-heating system based on induction-heating technology, in Japan.
The device’s Smartcore induction system heats the tobacco from within the new Terea Smartcore Stick. These newly designed sticks are to be used only with IQOS Iluma, which features an auto-start function that detects when the Terea stick is inserted and automatically turns on the device.
According to PMI, the bladeless IQOS devices offer a cleaner way to heat tobacco from the core without burning it. They also provide a more consistent experience and leave no tobacco residue, eliminating the need to clean the device. Additionally, the devices generate no combustion and no smoke. PMI says its market research indicates that IQOS Iluma provides a more pleasurable experience compared to previous IQOS generations.
“IQOS Iluma is our most innovative offering to date and the new flagship in our portfolio of science-backed, smoke-free products. Its breakthrough induction-heating technology heats tobacco from within, without burning, so there’s no smoke, no ash and, like previous IQOS devices, it emits, on average, 95 percent lower levels of harmful chemicals compared with cigarettes,” said Michele Cattoni, vice president of heated-tobacco platforms at PMI, in a statement.
“However, unlike our previous tobacco-heating systems, IQOS Iluma has no blade. That means no tobacco residue or cleaning—ever. With this, and other product features, we aim to address consumer pain points that may have hindered some adult smokers from beginning or maintaining their journey away from cigarettes in the past.”
IQOS Iluma is available in two versions—IQOS Iluma Prime and IQOS Iluma. Both devices use new induction-heating technology but offer different designs. IQOS Iluma Prime and IQOS Iluma are available in Japan for pre-order on IQOS.com beginning Aug. 17, 2021, and for purchase at IQOS stores on Aug. 18, 2021.
As of June 30, 2021, PMI’s smoke-free products are available in 67 markets. The company has stated its ambition to be present in 100 markets with its smoke-free products by 2025. There are more than 20 million users of the IQOS tobacco-heating system globally, and PMI estimates that more than 73 percent (approximately 14.7 million) of these men and women have switched completely to IQOS and stopped smoking with the balance in various stages of switching. PMI’s ambition is that by 2025, at least 40 million PMI cigarette smokers who would otherwise continue to smoke will have switched to smoke-free products. Furthermore, the company’s ambition is that more than half of its net revenues will come from smoke-free products by 2025.
August 17, 2021
Heating Products Exempted from Mexico ENDS Ban

Photo: niyazz
Mexico’s Supreme Court has ruled that heated tobacco products (HTP) will be exempted from a February 2020 presidential decree that bans importation of electronic nicotine delivery systems (ENDS), reports Filter.
Prior to the on July 16 ruling, manufacturers were able to import and sell HTPs legally using a loophole in the law called “habeas corpus trials.” But the loophole prevented the development of a fully regulated, legal market. The new presidential decree reverses that and allows for increased sales of these devices.
Vapor products that use e-liquids continue to be banned by the Mexican government. According to Roberto Sussman, a researcher at the National University of Mexico and president of Pro-Vapeo Mexico, the vapor market in Mexico has been functioning since 2009 as part of the huge informal economy, which employs more than 50 percent of the workforce and it is illegal but not criminal.

It was an embarrassment for President Andrés Manuel López Obrador, who has expressed opposition to foreign NGOs and agents meddling with Mexican government regulations.
Roberto Sussman, president, Po-Vapeo Mexico
More than 1.2 million Mexicans—1 percent of the adult population—use vapor products somewhat regularly, according to a survey by the Global State of Tobacco Harm Reduction.
According to Filter, a fatal blow to the HTP ban came when it was leaked that the draft of the decree was written by a lawyer working for the Campaign for Tobacco-Free Kids.
“It was an embarrassment for President Andrés Manuel López Obrador, who has expressed opposition to foreign NGOs and agents meddling with Mexican government regulations,” said Roberto Sussman.
It’s not the first time Mexico’s Supreme Court intervened in the country’s drug policy. On June 28, it stepped in to legalize marijuana, after lawmakers had failed to finalize the legislation the court demanded three years earlier.
July 23, 2021
Lil Moves into Southeastern Europe and Central Asia

Lil Solid 2.0 with Armenian health warnings
(Phot: KT&G)
KT&G’s Lil Solid 2.0 device and its Fiit heated-tobacco stick continues its global expansion with new launches in Central Asia and Southeastern Europe.
As part of a collaboration agreement between KT&G and Philip Morris International, Lil Solid 2.0 has been introduced into four Eurasian countries during the second quarter of 2021.
The device and its consumables debuted in Armenia on June 14. The products were also commercialized in Serbia and Kyrgyzstan on June 3 and 7, respectively. Lil Solid 2.0 and Fiit were previously introduced in Kazakhstan on May 13.
Lil Solid 2.0 is a second-generation model of KT&G’s heat-not-burn product with enhanced performance and design to improve consumer satisfaction. The product was first launched nationally in Korea in January this year. According to KT&G, it gained significant traction with its upgraded battery efficiency and induction heating technology.
The Lil Solid 2.0 device is available in two colors, Stone Grey and Cosmic Blue, in its new markets. The sticks come in seven types, including Fiit Regular, Fiit Viola And Fiit Crisp. Three or four types are sold in each country depending on the market situation.
Following the recent commercialization of Lil Solid 2.0 in four new markets, the Lil brand now is present in seven markets outside of South Korea. Previously, varieties of the brand were introduced in Russia, Ukraine and Japan.
“As Lil Solid 1.0 and Lil Hybrid 2.0 have been well received in their respective markets, we look forward for encouraging performance from Lil Solid 2.0 as well,” said Wang Seop Lim, chief of KT&G’s next-generation products business division, in a statement. “We will continue to provide broader choices to consumers outside Korea in the second half of this year through collaboration with PMI.”
June 16, 2021
Study: Impact of HNB No Less Harmful Than Cigarettes

Kuznietsov Dmitriy
The impact on lung cells of heat-not-burn (HNB) tobacco products may be no less harmful than that of conventional cigarettes, according to the authors of a small comparative study published by Thorax.
HNB products contain nicotine and tobacco but have been marketed by the tobacco industry as a less harmful alternative to conventional cigarettes on the grounds that they don’t produce specific harmful chemicals that are released when tobacco burns.
Smoking heightens the risk of coronary heart disease, stroke, peripheral artery disease, and abdominal aortic aneurysm, because it has a role in all stages of artery hardening and blockage. And it causes emphysema and pulmonary hypertension, because it contributes to the damage of blood vessels in the lungs.
Specifically, it contributes to endothelial dysfunction–whereby the lining of small and large blood vessels becomes abnormal, causing arteries to constrict instead of dilating, or blood vessels to become more inflamed; oxidative stress—an excess of harmful cellular by-products; platelet activation–creation of ‘sticky’ blood; and plaque development that can block arteries.
The researchers wanted to find out if these effects could also be observed in people who used HNB products.
So they compared endothelial dysfunction, oxidative stress and platelet activation in 20 non-smokers (average age 28), 20 long term conventional cigarette smokers (average age 27), and 20 long-term users of HNB products (average age 33).
The conventional smokers had been puffing away for an average of 3.5 years, getting through 13 sticks a day; the HNB users had been getting through around 11 products every day for an average of 5 years.
The findings showed that compared with not smoking, long term use of HNB products was associated with reduced endothelial function and increased oxidative stress and platelet activation.
And there were no significant differences between conventional cigarette smokers and users of HNB products.
This is an observational study, so it can’t establish cause. And the researchers acknowledge several limitations to their findings.
These include the small numbers of study participants involved, the lack of random allocation to each group, and the inability to confirm that a participant wasn’t a dual user of both conventional cigarettes and HNB products.
If confirmed by other large studies, these findings could provide evidence to strongly discourage non-smokers to start using [HNB products].
Lorenzo Loffredo et al.
Nevertheless, they conclude: “If confirmed by other large studies, these findings could provide evidence to strongly discourage non-smokers to start using [HNB products] and to encourage [conventional cigarette] smokers to quit smoking.”In a second linked study, a team of researchers assessed whether the use of HNB products helped Japanese workers to give up tobacco for good.
They offered a smoking cessation program to 158 users of conventional cigarettes (94) alone and/or HNB products (64) between November 2018 and April 2019.
The workplace program included prescription varenicrine or nicotine replacement therapy (NRT), counselling, and information about stopping smoking.
The quit rate was logged in August 2019, when 45 (29 percent) of the workers had successfully stopped using all tobacco products.
Those who availed themselves of pharmacological support were more likely to quit than those who didn’t (67 percent vs 11 percent) as were those who received counseling (69 percent vs 21 percent).
Analysis of the results showed that people who used varenicrine or NRT were three times more likely to stop smoking tobacco than those who didn’t.
But those who either used HNB products alone or in addition to conventional cigarettes (dual users) were 23 percent less likely than exclusive cigarette smokers to give up tobacco altogether, after accounting for age, tobacco dependence, previous quit attempts and use of pharmacological support.
This too is an observational study, and the researchers acknowledge that their study was small and restricted to healthy men in just one workplace. Smoking status was also self-reported and assessed at a single time point, and successful quitters weren’t asked how long they had stopped using tobacco.
But they point out that those who used HNB products in their study did so because they thought they were less harmful than conventional cigarettes.
“It is possible that the rhetorical phrases by tobacco industries attract and make consumers misunderstand that changing from cigarettes to [HNB products] can provide a healthier environment for themselves and their surroundings,” they suggest.
“Although [HNB products] are misunderstood to be less harmful, they expose users and bystanders to toxicants, and the evidence does not show that [they] will reduce tobacco-related diseases,” they add.
“Given that [HNB products] undermine cessation among smokers without providing health benefits, [they] should not be recommended for any purpose,” they conclude.
In a linked editorial, covering both research papers, Professor Irina Petrache of National Jewish Health, Denver, Colorado, and Esther de Boer of University of Colorado, agree.
“[Both] reports provide impetus to conduct larger randomized validating studies and to assess the impact of [HNB products] on additional health parameters. Their work enriches the mounting evidence that [HNB products] are not safer than [conventional cigarettes], suggesting that any tobacco use should be strongly discouraged,” they write.
April 22, 2021
Cambodia Cracks Down on Heated-Tobacco Products

Photo: IRIS AO from Pixabay
Cambodia’s National Authority for Combating Drugs (NACD) has instructed all relevant ministries and institutions to take immediate action to stop the use and commercialization of heated tobacco products (HTPs), reports The Phnom Penh Post.
“All forms of trafficking, trading and importation of HTPs must be stopped and information on import restrictions must be disseminated to all vendors and the public,” the NACD stated in a directive.
Citing the World Health Organization, the NACD said the use of cigars, electronic nicotine delivery devices (ENDS) and HTPs can lead to serious lung disease and even death. The announcement further said that using these products is also a motivating factor for people to use other illegal drugs.
Cambodia has restricted ENDS since February 2014, but its guidelines did not cover newer HTPs.
Deputy National Police chief Mak Chito said that in the past the authorities had confiscated many of these products. He said that although some other countries consider the use of these products legal, Cambodia does not allow it.
“In Cambodia, there are also bad people who are cheating by using methamphetamines or marijuana [with these devices],” he said.
March 22, 2021
PMI Probed for Heating Element Patent Breach

Photo: R.J. Reynolds Vapor Co.
The U.S. International Trade Commission (ITC) has opened a probe into vapor products imported by cigarette giant Philip Morris USA (PM) after R.J. Reynolds complained that PM’s tobacco-heating system infringes Reynolds’ patents, according to a report by Law360.
The investigation will determine whether the IQOS tobacco vaporizers marketed by Philip Morris and parent company Altria use tobacco-heating systems and sticks that violate patents for R.J. Reynolds’ Vuse vaping system. R.J. Reynolds seeks cease-and-desist orders barring imports of the allegedly infringing products.
The patents describe a device that heats tobacco held in a removable cartridge to 350 degrees when vapors containing nicotine are released without producing smoke, according to R.J. Reynolds’ April 9 complaint to the ITC.
R.J. Reynolds, which is owned by British American Tobacco, said Philip Morris has sold the alleged copycat IQOS system in the U.S. since October 2019 and has imported the product from manufacturers in Italy, Switzerland and Malaysia for years to use in clinical testing.
“We believe the allegations are without merit, and we are fully prepared to defend ourselves,” Philip Morris spokesman Corey Henry told Law360 in a statement Wednesday, noting the company has spent $7 billion developing its smoke-free tobacco products over the past two decades.
R.J. Reynolds filed a suit accusing Altria and Phillip Morris of six counts of trademark infringement in Virginia federal court the same day R.J. Reynolds filed its ITC petition. In that case, the company seeks treble damages and court declarations that Altria and Philip Morris have infringed its intellectual property.

Photo: PMI
May 18, 2020